IP Verse

Astrazeneca Pharmaceuticals competitive analysis

Latest publications and patents of Astrazeneca Pharmaceuticals New

Explore the latest publications and patents granted to Astrazeneca Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 24, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Astrazeneca Pharmaceuticals

EP4175620
Apr 10, 2024Compositions, Methods And Systems For Aerosol Drug DeliveryGranted And Under Opposition
EP4175619
Apr 10, 2024Compositions, Methods And Systems For Aerosol Drug DeliveryGranted And Under Opposition
EP4197528
Apr 3, 2024Compositions, Methods And Systems For Aerosol Drug DeliveryGranted And Under Opposition
EP2341905
Sep 13, 2023Sustained Release Formulations Using Non-Aqueous CarriersPatent Maintained As Amended
EP3329018
Mar 31, 2021Methods For Treating Hepcidin-Mediated DisordersRevoked
EP2347762
May 8, 2019Exendin For Treating Diabetes And Reducing Body WeightRevoked

Latest patents of Astrazeneca Pharmaceuticals opposed by its competitors

Explore Astrazeneca Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP4175619
Apr 10, 2024Compositions, Methods And Systems For Aerosol Drug Delivery2
EP4175620
Apr 10, 2024Compositions, Methods And Systems For Aerosol Drug Delivery1
EP4197528
Apr 3, 2024Compositions, Methods And Systems For Aerosol Drug Delivery1
EP2341905
Sep 13, 2023Sustained Release Formulations Using Non-Aqueous Carriers1
EP3329018
Mar 31, 2021Methods For Treating Hepcidin-Mediated Disorders1
EP2347762
May 8, 2019Exendin For Treating Diabetes And Reducing Body Weight2

Latest PTAB cases involving Astrazeneca Pharmaceuticals

Discover the latest PTAB cases involving Astrazeneca Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Astrazeneca Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ASTRAZENECA PHARMACEUTICALS LP - 7 - - Non-Active
BRAND MURRAY FULLER20 - - - Highly Aggressive
ELKINGTON AND FIFE85 - - - Highly Aggressive
INSTONE7 - - - Highly Aggressive